Variant report
Variant | esv18668 |
---|---|
Chromosome Location | chr11:57755622-57761480 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182930333 | chr11:57755641-57755642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571157820 | chr11:57755716-57755717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71454305 | chr11:57755721-57755722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374190836 | chr11:57755724-57755725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535339074 | chr11:57755797-57755798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556495247 | chr11:57755832-57755833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187270734 | chr11:57755858-57755859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191680791 | chr11:57755863-57755864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs55920028 | chr11:57755898-57755899 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs556757386 | chr11:57755912-57755913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542875107 | chr11:57755956-57755957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559413299 | chr11:57755999-57756000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545474227 | chr11:57756000-57756001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373636595 | chr11:57756008-57756009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184577212 | chr11:57756041-57756042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572756955 | chr11:57756042-57756043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140891936 | chr11:57756062-57756063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188026238 | chr11:57756117-57756118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529099240 | chr11:57756131-57756132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150159460 | chr11:57756179-57756180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572976567 | chr11:57756183-57756184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563617080 | chr11:57756262-57756263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192303195 | chr11:57756290-57756291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544913289 | chr11:57756332-57756333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552240749 | chr11:57756361-57756362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570867237 | chr11:57756375-57756376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535300641 | chr11:57756391-57756392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11512731 | chr11:57756402-57756403 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs568795254 | chr11:57756475-57756476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535654957 | chr11:57756486-57756487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557239308 | chr11:57756494-57756495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533417597 | chr11:57756519-57756520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371547681 | chr11:57756542-57756543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185792827 | chr11:57756567-57756568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs11512732 | chr11:57756568-57756569 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs189402084 | chr11:57756569-57756570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557293423 | chr11:57756592-57756593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11512733 | chr11:57756605-57756606 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs540109364 | chr11:57756616-57756617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555220907 | chr11:57756634-57756635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573913841 | chr11:57756685-57756686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544071615 | chr11:57756695-57756696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562704719 | chr11:57756711-57756712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374043936 | chr11:57756746-57756747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35163247 | chr11:57756886-57756887 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs549631834 | chr11:57756909-57756910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34243081 | chr11:57756933-57756934 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs371624113 | chr11:57756959-57756960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs75695577 | chr11:57756960-57756961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551607065 | chr11:57756998-57756999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:57749800-57758800 | Weak transcription | HepG2 | liver |
2 | chr11:57758800-57760000 | Enhancers | HepG2 | liver |